- Titre
- How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform? Reply
- Créateurs - sans rôle
- Mathieu Bastard - Epictr, Paris, FranceMaryline Bonnet - Epictr, Paris, FrancePhilipp du Cros - Med Sans Frontieres, London, EnglandAtadjan Karimovich Khamraev - Tashkent Pediat Med Inst, Tashkent, UzbekistanArmen Hayrapetyan - Natl TB Control Off, Yerevan, ArmeniaKamene Kimenye - Programmat Management Drug Resistant TB, Nairobi, KenyaShazina Khurkhumal - Natl TB Program, Sukhumi, GeorgiaThemba Dlamini - Minist Hlth, TB Natl Control Program, Mbanane, EswatiniAlex Telnov - Med Sans Frontieres, Geneva, SwitzerlandElisabeth Sanchez-Padilla - Epictr, Paris, FranceCathy Hewison - Med Sans Frontieres, Paris, FranceFrancis Varaine - Med Sans Frontieres, Paris, France
- Détails de publication
- American journal of respiratory and critical care medicine, Vol.192(1), pp.117-118
- Éditeur
- Amer Thoracic Soc
- Nombre de pages
- 2
- Identifiants
- 99158564009311
- Unité académique
- Recherches translationnelles sur le VIH et les Maladies Infect. Endém. émerg. - TransVIHMI
- Langue
- English
- Type de ressource
- Journal article
Article de revue
How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform? Reply
American journal of respiratory and critical care medicine, Vol.192(1), pp.117-118
01/07/2015
PMID: 26131996
Indicateurs
1 Consultations de la notice